您的位置: 首页 > 农业专利 > 详情页

ANTICORPS ANTI-B7-H4 ET LEURS PROCEDES D'UTILISATION
专利权人:
FIVE PRIME THERAPEUTICS; INC.
发明人:
KAPLAN, CHARLES,HOUSER, DERRICK,BORGES, LUIS,BRATTICH, GLORIA,BELLOVIN, DAVID,KEMP, FELICIA,GHODDUSI, MAJID,NIELSON, NELS P.,MILLER, KATHY,SCHMIDT, MAIKE
申请号:
CA3070774
公开号:
CA3070774A1
申请日:
2018.08.23
申请国别(地区):
CA
年份:
2019
代理人:
摘要:
The present disclosure provides antibodies and antigen-binding fragments thereof that specifically bind to human B7-H4 (and optionally cynomolgus monkey, mouse, and/or rat B7- H4) and compositions comprising such antibodies or antigen-binding fragments thereof. In a specific aspect, the antibodies or antigen-binding fragments thereof that specifically bind to human B7-H4 increase T cell proliferation, increase interferon-gamma production, and/or deplete B7-H4 expressing cells via ADCC activity. The present disclosure also provides methods for treating disorders, such as cancer, by administering an antibody or antigen-binding fragment thereof that specifically binds to human B7-H4.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/
相关发明人
相关专利

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充